Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
about
Catheter ablation for paroxysmal and persistent atrial fibrillationUse of CHADS₂ and CHA₂DS₂-VASc scores to predict subsequent myocardial infarction, stroke, and death in patients with acute coronary syndrome: data from Taiwan acute coronary syndrome full spectrum registryTermination of sustained atrial flutter and fibrillation using low-voltage multiple-shock therapyA common data model to assess cardiovascular hospitalization and mortality in atrial fibrillation patients using administrative claims and medical recordsPrognostic impact of renal dysfunction in patients with acute coronary syndrome-role beyond the CHA2 DS2 -VASc score: Data from Taiwan acute coronary syndrome full spectrum registry.Evaluation of the CHADS2 risk score on short- and long-term all-cause and cardiovascular mortality after syncope.Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study).Usefulness of a low CHADS2 or CHA2DS2-VASc score to predict normal diagnostic testing in emergency department patients with an acute exacerbation of previously diagnosed atrial fibrillationWarfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty.Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds.CHADS2 Score is a Poor Predictor of Non-cerebral Acute Arterial Occlusion in Patients with Non-valvular Atrial Fibrillation.CHADS2 and CHA2DS2-VASc score to assess risk of stroke and death in patients paced for sick sinus syndrome.Adverse Outcomes from Atrial Fibrillation;Mechanisms, Risks, and Insights Learned from Therapeutic Options.Stroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation.Solutions to Reduce Cardiovascular Events in Patients with Atrial Fibrillation.Systematic review and meta-analysis of surgical ablation for atrial fibrillation during mitral valve surgery.New approaches to atrial fibrillation management: treat the patient, not the ECG.Rhythm control strategies and the role of antiarrhythmic drugs in the management of atrial fibrillation: focus on clinical outcomes.Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis.Predictive ability of the CHADS2 and CHA2DS2-VASc scores for stroke after transcatheter aortic balloon-expandable valve implantation: an Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) sub-analysis.Risk stratification using the CHA2DS2-VASc score in patients with coronary heart disease undergoing percutaneous coronary intervention; sub-analysis of SHINANO registry.CHADS2 and CHA2DS2-VASc scores are independently associated with incident atrial fibrillation: the Catanzaro Atrial Fibrillation Project.The Management and Prognostic Factors of Acute Coronary Syndrome: Evidence from the Taiwan Acute Coronary Syndrome Full Spectrum Registry.The Association between CHA2DS2-VASc Score and Mortality in Patients with Heart Failure with Reduced Ejection Fraction.Is CHA2DS2-VASc Score Different in Patients with Non-valvular Atrial Fibrillation Suffering from Cerebral and Non-cerebral Thromboembolism?CHA2DS2-VASc Score in Thromboembolism.Atrial fibrillation and CHADS2 score as mortality predictors in young versus elderly patients undergoing coronary angiography.Anticoagulant use in atrial fibrillation and risk of dementia: review of contemporary knowledge.Efficacy and Safety of Warfarin Experience in a Stroke Polyclinic in Stroke Patients.Long-term results of radiofrequency maze procedure for persistent atrial fibrillation with concomitant mitral surgery.Prevention of Stroke in Patients With Atrial Fibrillation.To anticoagulate or not to anticoagulate? That is the question : A Medline-based quantitative approach to share evidence on common clinical problems.
P2860
Q24200210-E5018DFC-FBCC-4815-9F6C-B72C08C3E982Q30000646-A444EFF1-4B77-491C-A362-00DA97E30A1EQ30518791-78BF8063-FA1A-4611-9506-F5C55A49E994Q30886141-FB6055E6-D510-40E0-8446-5B9D664553ECQ31005750-DF4C8CD9-79D8-401C-A610-9F8DE16C37AEQ33162429-EB7651E1-92A5-41FC-B79B-931D6A381D7AQ33775363-1EF3B177-F860-49AC-8EB0-0E422DEB5C9BQ34163339-8137FB4F-2C99-4285-9486-51AF457D58B7Q34938763-1E31E905-8EB3-4069-8C07-6D43D495DEE0Q35335685-B693FF2D-49DE-46E8-B53A-780D72B893C3Q36679380-4EB85600-40EF-4A79-BD5B-8209C651E55DQ36876669-1F7B275E-BB53-41D4-9C31-0F95237484DBQ37495633-06707165-2446-4E3C-90AD-5749F147ED14Q37495877-A8D14C36-5B5C-4736-BE75-E020DDA0A1EDQ37496280-41669195-97FD-42DB-BA8F-CC8BF3804635Q37523118-2EDF2643-4832-41FE-A18A-0BF272BB571CQ37719641-6642F49A-E305-4BAE-B21E-17E52DB3F97AQ37812344-9A8C78A8-9FA1-4FB9-9CB0-3B5F37BCD829Q38043541-96DCF2BF-A789-4E59-93C4-732A61A47FF7Q40677073-DC3B5346-BBC6-4FDC-A516-277962FB137EQ40963983-F19F7E5D-A3A2-4621-BCA8-A962895513E4Q40979000-5EE1085A-5A43-4C9D-B5F5-AB4C3BCC1DBFQ42339373-19C9FE43-278E-485E-BA3C-E78CD26AF328Q42339386-421AF855-3550-4757-962E-3F20919C394CQ47099070-5D470159-EAFB-4A48-BAD1-DB3E7DF2CD8FQ47119794-9606A033-CEE5-4D5D-9D5E-E6C86A036E6FQ47407548-3E2F29F2-DD55-48A2-84B3-5E0871580C0CQ49177940-3FD102C8-685A-44BF-8612-83E01CFC0AD8Q49189332-A7425B27-B8D1-485D-A48B-885CD792F019Q53762661-2CFAC4D7-0212-4EA7-9936-AC7129AC23D2Q53973148-AAB778FA-112F-46D1-8FAA-E91CF2663977
P2860
Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Atrial fibrillation significan ...... ed by the CHADS2 risk factors.
@en
Atrial fibrillation significan ...... ed by the CHADS2 risk factors.
@nl
type
label
Atrial fibrillation significan ...... ed by the CHADS2 risk factors.
@en
Atrial fibrillation significan ...... ed by the CHADS2 risk factors.
@nl
prefLabel
Atrial fibrillation significan ...... ed by the CHADS2 risk factors.
@en
Atrial fibrillation significan ...... ed by the CHADS2 risk factors.
@nl
P2093
P2860
P1476
Atrial fibrillation significan ...... ed by the CHADS2 risk factors.
@en
P2093
Benjamin D Horne
Brian G Crandall
Donald L Lappé
J Peter Weiss
Jeffrey L Anderson
Jeffrey S Osborne
John D Day
Joseph B Muhlestein
Mark A Crandall
T Jared Bunch
P2860
P304
P356
10.1111/J.1540-8159.2009.02427.X
P577
2009-08-01T00:00:00Z